Skip to content
The Cancer History Project
HOME
ABOUT
THE CANCER HISTORY PROJECT
THE CANCER LETTER
EDITORIAL BOARD
SPONSORS
CONTRIBUTORS
TCL ARCHIVES
LATEST ARTICLES
Search for:
Search
ARCHIVES
FDA Should Delay Provenge Decision Pending Definitive Trial Results, ODAC Chairman Writes.
This article is from
The Cancer Letter
archive.
Vol. 33 No. 16 | April 27, 2007
Download PDF
Visit The Full Archive
Related Articles
Primary Source
NCCS Networker Volume 4 Issue 4, Fall 1990
September 13, 1990
TCL Archive
NCI SBIR Offers $10 million in 10 Awards
February 18, 2011
TCL Archive
NCAB Committee Ok’s Recompetition of OD Support Contract
May 22, 1992
TCL Archive
Also R01 payline likely to fall below 20th percentile in FY04.
September 26, 2003
TCL Archive
New Protocol Could Improve Survival Of Rare Brain Tumor
October 30, 2009
TCL Archive
Hawaiian Have Highest Cancer Rate In U.S.
April 29, 1983